Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Spain | 10 | 2021 | 15545 | 0.42 | Why? |
| Body Mass Index | 1 | 2021 | 4306 | 0.36 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.26 | Why? |
| Hospitalization | 7 | 2021 | 54280 | 0.25 | Why? |
| Cohort Studies | 9 | 2021 | 36005 | 0.25 | Why? |
| Psychoses, Substance-Induced | 1 | 2021 | 91 | 0.21 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.21 | Why? |
| Viral Vaccines | 1 | 2021 | 7560 | 0.20 | Why? |
| Chemotherapy, Adjuvant | 1 | 2021 | 606 | 0.18 | Why? |
| Adolescent | 9 | 2021 | 86841 | 0.18 | Why? |
| Comorbidity | 5 | 2021 | 34796 | 0.17 | Why? |
| Prevalence | 5 | 2021 | 25773 | 0.16 | Why? |
| Young Adult | 10 | 2021 | 93724 | 0.16 | Why? |
| Influenza, Human | 4 | 2021 | 10779 | 0.16 | Why? |
| Republic of Korea | 4 | 2021 | 5858 | 0.16 | Why? |
| Databases, Factual | 2 | 2021 | 6248 | 0.15 | Why? |
| United States | 7 | 2021 | 46150 | 0.13 | Why? |
| Aged, 80 and over | 7 | 2021 | 88759 | 0.13 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.12 | Why? |
| Suicidal Ideation | 1 | 2021 | 1226 | 0.12 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.11 | Why? |
| Age Distribution | 1 | 2021 | 3567 | 0.11 | Why? |
| Aged | 10 | 2021 | 215776 | 0.11 | Why? |
| Adult | 10 | 2021 | 244371 | 0.10 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.09 | Why? |
| Germany | 2 | 2021 | 9196 | 0.09 | Why? |
| Male | 11 | 2021 | 367725 | 0.09 | Why? |
| Female | 11 | 2021 | 380317 | 0.09 | Why? |
| Suicide | 1 | 2021 | 1500 | 0.09 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.09 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.08 | Why? |
| Symptom Assessment | 1 | 2021 | 4967 | 0.08 | Why? |
| Sex Factors | 2 | 2021 | 11014 | 0.08 | Why? |
| Diagnosis, Differential | 1 | 2021 | 7220 | 0.08 | Why? |
| Antirheumatic Agents | 1 | 2021 | 3023 | 0.08 | Why? |
| France | 1 | 2021 | 12074 | 0.07 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.07 | Why? |
| United Kingdom | 2 | 2021 | 18046 | 0.07 | Why? |
| Population Surveillance | 1 | 2021 | 4967 | 0.07 | Why? |
| Ambulatory Care | 1 | 2021 | 4947 | 0.06 | Why? |
| Child | 3 | 2021 | 70012 | 0.06 | Why? |
| Humans | 12 | 2021 | 930598 | 0.06 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.06 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.06 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.06 | Why? |
| Adaptation, Psychological | 1 | 2020 | 4996 | 0.06 | Why? |
| Administrative Claims, Healthcare | 1 | 2021 | 124 | 0.06 | Why? |
| Infant | 2 | 2021 | 30274 | 0.06 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.05 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.05 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.05 | Why? |
| Fluoroquinolones | 1 | 2021 | 235 | 0.05 | Why? |
| Ceftriaxone | 1 | 2021 | 365 | 0.05 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.04 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.04 | Why? |
| Social Change | 1 | 2020 | 303 | 0.04 | Why? |
| Stress, Psychological | 1 | 2020 | 10231 | 0.04 | Why? |
| Depression | 1 | 2021 | 14116 | 0.04 | Why? |
| Mental Health | 1 | 2020 | 15770 | 0.03 | Why? |
| Enoxaparin | 1 | 2021 | 1064 | 0.03 | Why? |
| Safety | 1 | 2021 | 1583 | 0.03 | Why? |
| Drug Combinations | 1 | 2021 | 3852 | 0.03 | Why? |
| Electronic Health Records | 1 | 2021 | 3492 | 0.02 | Why? |
| Arthritis, Rheumatoid | 1 | 2021 | 2043 | 0.02 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.02 | Why? |
| Ritonavir | 1 | 2021 | 4212 | 0.02 | Why? |
| Azithromycin | 1 | 2021 | 3943 | 0.02 | Why? |
| Vitamin D | 1 | 2021 | 2904 | 0.02 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.02 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |